研究者詳細 - 岡田　龍

写真a

オカダ　リュウ

岡田　龍

OKADA Ryu

所属

大学院医学系研究科特任助教

学位 1

博士(学術) （ 2024年9月埼玉大学）

学位の先頭へ▲

経歴 1

名古屋大学高等研究院特任助教

2024年11月 - 現在

　詳細を見る

国名：日本国

経歴の先頭へ▲

論文 9

Near infrared photo-bacterialflora modulation technology realized controlling periodontitis: modulation of disease-associated dysbiosis in oral microbiota using near infrared photo-antibacterial targeting therapy (NIR-PAT2). 国際誌

Hiroshi Maruyama, Kazuhide Sato, Kiyoshi Sakai, Hirotoshi Yasui, Ryu Okada, Li Xinheng, Koji Umeda, Shofiqur Rahman, Van Sa Nguyen, Hideharu Hibi

Journal of translational medicine 24 巻 ( 1 ) 2026年6月

　詳細を見る

記述言語：英語掲載種別：研究論文（学術雑誌）

BACKGROUND: Periodontitis is a complex polymicrobial disease driven by synergistic interactions within a dysbiotic oral community. Within this network, Porphyromonas gingivalis acts as a keystone pathogen that orchestrates the pathogenic transformation of the microbiota. Current broad-spectrum antimicrobials often disrupt the entire microbial ecosystem and release immunogenic lipopolysaccharides (LPS). We aimed to develop a targeted approach, Near-Infrared Photo-Antibacterial Targeting Therapy (NIR-PAT2), using an antibody-photosensitizer conjugate (IgY-IR700) to reduce P. gingivalis load within this polymicrobial complex and modulate the community profile. METHODS: We evaluated the binding and bactericidal mechanism of NIR-PAT2 in vitro compared to antimicrobial photodynamic therapy (aPDT), using scanning electron microscopy (SEM) and endotoxin assays. In vivo, a ligature-induced periodontitis mouse model was used to assess therapeutic effects on alveolar bone resorption and microbiome community structure (16 S rRNA sequencing). RESULTS: In vitro, NIR-PAT2 eliminated P. gingivalis without affecting human cells. SEM analysis revealed a distinct mechanism: unlike aPDT, which caused bacterial disintegration, NIR-PAT2 induced lethal transmembrane perforations while maintaining structural integrity. In parallel, endotoxin assays demonstrated that NIR-PAT2 treatment significantly suppressed LPS release compared to aPDT. In vivo, NIR-PAT2 treatment significantly inhibited alveolar bone resorption. Crucially, microbiome analysis demonstrated that NIR-PAT2 did not merely eliminate the environment but induced a compositional shift toward a health-associated profile. By suppressing Porphyromonas, the treatment facilitated the partial restoration of commensal genera such as Streptococcus, disrupting the dysbiotic network. CONCLUSIONS: This study suggests that NIR-PAT2 functions as a "Near-Infrared Photo-Bacterialflora Modulation (NIR-PBAM)" technology. By targeting a keystone pathogen within the polymicrobial community, NIR-PBAM offers a strategy to partially restore microbial balance while presenting a potential advantage in limiting LPS release, thus overcoming the ecological disruption caused by conventional broad-spectrum antimicrobials.

DOI： 10.1186/s12967-026-08336-2

PubMed
Proton microbeam characterization using a single-particle scintillator

Katsunori Yogo, Ryu Okada, Tatsuya Kameyama, Kazutaka Akiyoshi, Tsukasa Torimoto, Masao Yoshino, Hiroshi Yasuda, Seiichi Yamamoto, Daisuke OHSAWA

Physics in Medicine & Biology 2026年4月

　詳細を見る

掲載種別：研究論文（学術雑誌）出版者・発行元：IOP Publishing

Abstract

Objective. To develop a simple and high-resolution method for measuring both the local dose and lateral beam width of a microproton beam using light emission from a single micron-sized scintillator particle. Approach. We used ZnS:Ag (silver-activated zinc sulfide) scintillator powder, known for its favorable dose response and peak emission at 450 nm. Proton microbeams (3.4 MeV) were delivered using the Single-Particle Irradiation system to Cell (SPICE) at the National Institute for Quantum and Radiological Science and Technology. The scintillator powder was dispersed on a thin film placed over a cell culture dish, and the emission from individual particles was recorded using a microscope-coupled camera. By scanning the proton beam in 400 nm steps across the particles, we measured variations in light intensity to evaluate both irradiation dose and beam profile. Main results. The luminescence intensity increased linearly with irradiation time and varied consistently with beam position relative to the particle center. Despite the particle diameter exceeding the beam width, emission modulation enabled precise localization of the beam center. Measured lateral beam widths using four particles with diameters of approximately 8 μm were 1.9 ± 0.3 μm in the X direction and 1.8 ± 0.4 μm in the Y direction, demonstrating sub-micron resolution beyond the imaging system’s pixel size. Significance. This method enables simultaneous estimation of dose and beam width using a single scintillator particle, without requiring complex microdosimetric equipment. It provides a practical and accurate tool for microbeam characterization, contributing to improved dosimetry and targeting precision in radiobiological research at the cellular and subcellular scale. By exploiting emission modulation within a single scintillator particle, beam profiles can be reconstructed with spatial precision beyond the optical pixel resolution.

DOI： 10.1088/1361-6560/ae63a1

その他リンク： https://iopscience.iop.org/article/10.1088/1361-6560/ae63a1/pdf
Synthetic lethality of EZH2 and DNMT Inhibition suppresses neuroblastoma proliferation via MYCN destabilization

Yuki Endo, Ryuichi P. Sugino, Hisanori Takenobu, Kyosuke Mukae, Ryu Okada, Yoshitaka Shinno, Masayuki Haruta, Shunpei Satoh, Jesmin Akter, Naoko Hattori, Atsuko Nakazawa, Toshikazu Ushijima, Akira Nakagawara, Miki Ohira, Masaki Nio, Takehiko Kamijo

BMC Cancer 2025年11月

　詳細を見る

記述言語：英語掲載種別：研究論文（学術雑誌）

DOI： 10.1186/s12885-025-14882-7
Noncanonical PRC1.1 targets BTG2 to retain cyclin gene expression and cell growth in neuroblastoma

Shunpei Satoh, Mariko Hasegawa, Ryu Okada, Masayuki Haruta, Hisanori Takenobu, Miki Ohira, Takehiko Kamijo

Oncogenesis 2025年6月

　詳細を見る

記述言語：英語掲載種別：研究論文（学術雑誌）

DOI： 10.1038/s41389-025-00561-6
Photoinduced Actin Aggregation Involves Cell Death: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy

Kazuhide Sato, Tomoko Okada, Ryu Okada, Hirotoshi Yasui, Mizuki Yamada, Yoshitaka Isobe, Yuko Nishinaga, Misae Shimizu, Chiaki Koike, Rika Fukushima, Kazuomi Takahashi, Shunichi Taki, Ayako Kato, Mitsuo Sato, Toshihiko Ogura

ACS Nano 2025年3月

　詳細を見る

記述言語：英語掲載種別：研究論文（学術雑誌）

DOI： 10.1021/acsnano.5c00104
L3MBTL2 maintains MYCN‐amplified neuroblastoma cell proliferation through silencing NRIP3 and BRME1 genes

Ryu Okada, Hisanori Takenobu, Shunpei Satoh, Ryuichi P. Sugino, Ritsuko Onuki, Masayuki Haruta, Kyosuke Mukae, Atsuko Nakazawa, Jesmin Akter, Miki Ohira, Takehiko Kamijo

Genes to Cells 2024年10月

　詳細を見る

記述言語：英語掲載種別：研究論文（学術雑誌）

<jats:title>Abstract</jats:title><jats:p>Epigenetic alterations critically affect tumor development. Polycomb‐group complexes constitute an evolutionarily conserved epigenetic machinery that regulates stem cell fate and development. They are implicated in tumorigenesis, primarily via histone modification. Polycomb repressive complex 1 (PRC1) complexes 1–6 (PRC1.1–6) mediate the ubiquitination of histone H2A on lysine 119 (H2AK119ub). Here, we studied the functional roles of a PRC1.6 molecule, L3MBTL2, in neuroblastoma (NB) cells. <jats:italic>L3MBTL2</jats:italic>‐knockout and knockdown revealed that L3MBTL2 depletion suppressed NB cell proliferation via cell‐cycle arrest and gamma‐H2A.X upregulation. <jats:italic>L3MBTL2‐</jats:italic>knockout profoundly suppressed xenograft tumor formation. Transcriptome analysis revealed suppressed cell‐cycle‐related and activated differentiation‐related pathways. <jats:italic>Break repair meiotic recombinase recruitment factor 1</jats:italic> (<jats:italic>BRME1</jats:italic>) and <jats:italic>nuclear receptor interacting protein 3</jats:italic> (<jats:italic>NRIP3</jats:italic>) were notably de‐repressed by <jats:italic>L3MBTL2</jats:italic>‐knockout. The deletion of <jats:italic>L3MBTL2</jats:italic> reduced enrichment of H2AK119ub and PCGF6 at transcriptional start site proximal regions of the targets. Add‐back studies unveiled the importance of L3MBTL2‐BRME1 and ‐NRIP3 axes for NB cell proliferation. We further manifested the association of MYCN with de‐repression of <jats:italic>NRIP3</jats:italic> in an <jats:italic>L3MBTL2</jats:italic>‐deficient context. Therefore, this study first revealed the significance of <jats:italic>L3MBTL2‐</jats:italic>mediated gene silencing in MYCN‐amplified NB cells.</jats:p>

DOI： 10.1111/gtc.13148
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors Open Access

Sultana Parvin, Jesmin Akter, Hisanori Takenobu, Yutaka Katai, Shunpei Satoh, Ryu Okada, Masayuki Haruta, Kyosuke Mukae, Tomoko Wada, Miki Ohira, Kiyohiro Ando, Takehiko Kamijo

BMC Cancer 2023年4月

　詳細を見る

記述言語：英語掲載種別：研究論文（学術雑誌）

<jats:title>Abstract</jats:title><jats:sec>
<jats:title>Background</jats:title>
<jats:p>Genomic alterations, including loss of function in chromosome band 11q22-23, are frequently observed in neuroblastoma, which is the most common extracranial childhood tumour. In neuroblastoma, <jats:italic>ATM</jats:italic>, a DNA damage response-associated gene located on 11q22-23, has been linked to tumorigenicity. Genetic changes in <jats:italic>ATM</jats:italic> are heterozygous in most tumours. However, it is unclear how ATM is associated with tumorigenesis and cancer aggressiveness.</jats:p>
</jats:sec><jats:sec>
<jats:title>Methods</jats:title>
<jats:p>To elucidate its molecular mechanism of action, we established <jats:italic>ATM</jats:italic>-inactivated NGP and CHP-134 neuroblastoma cell lines using CRISPR/Cas9 genome editing. The knock out cells were rigorously characterized by analyzing proliferation, colony forming abilities and responses to PARP inhibitor (Olaparib). Western blot analyses were performed to detect different protein expression related to DNA repair pathway. ShRNA lentiviral vectors were used to knockdown ATM expression in SK-N-AS and SK-N-SH neuroblastoma cell lines. <jats:italic>ATM</jats:italic> knock out cells were stably transfected with FANCD2 expression plasmid to over-expressed the FANCD2. Moreover, knock out cells were treated with proteasome inhibitor MG132 to determine the protein stability of FANCD2. FANCD2, RAD51 and γH2AX protein expressions were determined by Immunofluorescence microscopy.</jats:p>
</jats:sec><jats:sec>
<jats:title>Results</jats:title>
<jats:p>Haploinsufficient <jats:italic>ATM</jats:italic> resulted in increased proliferation (<jats:italic>p</jats:italic> < 0.01) and cell survival following PARP inhibitor (olaparib) treatment. However, complete <jats:italic>ATM</jats:italic> knockout decreased proliferation (<jats:italic>p</jats:italic> < 0.01) and promoted cell susceptibility to olaparib (<jats:italic>p</jats:italic> < 0.01). Complete loss of ATM suppressed the expression of DNA repair-associated molecules FANCD2 and RAD51 and induced DNA damage in neuroblastoma cells. A marked downregulation of FANCD2 expression was also observed in shRNA-mediated ATM-knockdown neuroblastoma cells. Inhibitor experiments demonstrated that the degradation of FANCD2 was regulated at the protein level through the ubiquitin–proteasome pathway. Reintroduction of FANCD2 expression is sufficient to reverse decreased proliferation mediated by ATM depletion.</jats:p>
</jats:sec><jats:sec>
<jats:title>Conclusions</jats:title>
<jats:p>Our study revealed the molecular mechanism underlying <jats:italic>ATM</jats:italic> heterozygosity in neuroblastomas and elucidated that <jats:italic>ATM</jats:italic> inactivation enhances the susceptibility of neuroblastoma cells to olaparib treatment. These findings might be useful in the treatment of high-risk NB patients showing <jats:italic>ATM</jats:italic> zygosity and aggressive cancer progression in future.</jats:p>
</jats:sec>

DOI： 10.1186/s12885-023-10772-y

Open Access
Polycomb group protein BMI1 protects neuroblastoma cells against DNA damage-induced apoptotic cell death Open Access

Nobuhiro Akita, Ryu Okada, Kyosuke Mukae, Ryuichi P. Sugino, Hisanori Takenobu, Koji Chikaraishi, Hidemasa Ochiai, Yohko Yamaguchi, Miki Ohira, Haruhiko Koseki, Takehiko Kamijo

Experimental Cell Research 2023年1月

　詳細を見る

掲載種別：研究論文（学術雑誌）

DOI： 10.1016/j.yexcr.2022.113412

Open Access
Polycomb <scp>EZH1</scp> regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN Open Access

Yoshitaka Shinno, Hisanori Takenobu, Ryuichi P. Sugino, Yuki Endo, Ryu Okada, Masayuki Haruta, Shunpei Satoh, Kyosuke Mukae, Dilibaerguli Shaliman, Tomoko Wada, Jesmin Akter, Kiyohiro Ando, Atsuko Nakazawa, Hideo Yoshida, Miki Ohira, Tomoro Hishiki, Takehiko Kamijo

Cancer Science 2022年12月

　詳細を見る

記述言語：英語掲載種別：研究論文（学術雑誌）

<jats:title>Abstract</jats:title><jats:p>In the present study, we found that EZH1 depletion in <jats:italic>MYCN</jats:italic>‐amplified neuroblastoma cells resulted in significant cell death as well as xenograft inhibition. EZH1 depletion decreased the level of H3K27me1; the interaction and protein stabilization of MYCN and EZH1 appear to play roles in epigenetic transcriptional regulation. Transcriptome analysis of EZH1‐depleted cells resulted in downregulation of the cell cycle progression‐related pathway. In particular, Gene Set Enrichment Analysis revealed downregulation of reactome E2F‐mediated regulation of DNA replication along with key genes of this process, <jats:italic>TYMS</jats:italic>, <jats:italic>POLA2</jats:italic>, and <jats:italic>CCNA1</jats:italic>. <jats:italic>TYMS</jats:italic> and <jats:italic>POLA2</jats:italic> were transcriptionally activated by MYCN and EZH1‐related epigenetic modification. Treatment with the EZH1/2 inhibitor UNC1999 also induced cell death, decreased H3K27 methylation, and reduced the levels of <jats:italic>TYMS</jats:italic> in neuroblastoma cells. Previous reports indicated neuroblastoma cells are resistant to 5‐fluorouracil (5‐FU) and TYMS (encoding thymidylate synthetase) has been considered the primary site of action for folate analogues. Intriguingly, UNC1999 treatment significantly sensitized MYCN‐amplified neuroblastoma cells to 5‐FU treatment, suggesting that EZH inhibition could be an effective strategy for development of a new epigenetic treatment for neuroblastoma.</jats:p>

DOI： 10.1111/cas.15555

Open Access

▼全件表示

論文の先頭へ▲

MISC 1

近赤外光線免疫療法の基礎と応用: メカニズム,デバイス開発,併用治療戦略

岡田龍, 岡田龍, 岡田龍, 佐藤和秀, 佐藤和秀, 佐藤和秀

Thermal Medicine42 巻 ( 1 ) 2026年

　詳細を見る

J-GLOBAL

MISCの先頭へ▲